CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Appendix 4C - quarterly, page-3

  1. 128 Posts.
    lightbulb Created with Sketch. 27

    Agree that theyvare doing good research regarding use of cannabidiol  in animals.

    but as a shareholder I am worried that these are probably not patented formulations and anyone could theoretically copy and sell..

    Cannpal may be credited with the research findings but will that lead to commercial benefit?

 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.